NCBP2 antisense RNA 1 (NCBP2-AS1)

NCBP2 antisense RNA 1 (NCBP2-AS1) is a human long non-coding RNA (lncRNA) transcribed from the strand opposite to the protein-coding NCBP2 locus. Antisense lncRNAs like NCBP2-AS1 can regulate gene expression via diverse mechanisms, including chromatin remodeling, transcriptional interference, and post-transcriptional effects by binding to cognate mRNA. They typically function in cis (nearby genes on the same chromosome) or in trans (regulating genes elsewhere). While lncRNAs are increasingly implicated in both normal cell functions and disease (such as cancer or infection), the specific roles of NCBP2-AS1 remain largely uncharacterized. Some data suggest its altered expression in disease contexts such as COVID-19, but its precise functions, disease relevance, and utility as a therapeutic target or biomarker remain to be established. If you are seeking information on the protein NCBP2 (Nuclear cap-binding protein subunit 2), which is a component of the nuclear cap-binding complex involved in mRNA processing and has roles in cancer biology, please specify; the entry above is distinct from the protein target.

Other names

ncRNA NCBP2-AS1long non-coding RNA NCBP2-AS1antisense lncRNA to NCBP2

If targeted, mechanisms might involve: - RNase H-mediated RNA degradation - Modulation of transcription via chromatin alterations or transcription interference These are general mechanisms for antisense RNA targeting, not NCBP2-AS1-specific therapies.